Pharmacological treatments against AUD, opioid use disorder (OUD) and tobacco use disorder are available (see Table 1) (European Monitoring Centre for Drugs and Drug Addiction, 2012
spending on prescription medication grew 11.4% in 2024 (up from 4.9% in 2023), a $50 billion increase, and GLP-1 medications accounted for 29% of this growth
The therapeutic effects of TGR5 agonists could be improved in combinatorial therapy
By incorporating glutathione into your daily routine, you can support your body's natural defenses, enhance detoxification, and promote overall well-being
It's messing with my head in a big way
Retatrutide is currently being evaluated in Phase 3 clinical trials, which are the large-scale studies required to confirm efficacy and safety before a regulatory submission can be made